UniProtKB/Swiss-Prot P12821: Variant p.Arg379Gln

Angiotensin-converting enzyme
Gene: ACE
Feedback?

Variant information Variant position:

379 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Glutamine (Q) at position 379 (R379Q, p.Arg379Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs13306085 [ dbSNP | Ensembl ]

Sequence information Variant position:

379 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1306 The length of the canonical sequence.
Location on the sequence:

CHASAWDFYNRKDFRIKQCT R VTMDQLSTVHHEMGHIQYYL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         CHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYL

Chimpanzee                    CHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYL

Mouse                         CHASAWDFYNRKDFRIKQCTRVTMEQLATVHHEMGHVQYYL

Rat                           CHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHVQYYL

Pig                           CHASAWDFYNRKDFRIKQCTQVTMDQLSTVHHEMGHVQYYL

Bovine                        CHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHVQYYL

Rabbit                        CHASAWDFYNRKDFRIKQCTQVTMDQLSTVHHEMGHVQYYL

Chicken                       CHASAWDFYNRKDFRIKQCTTVTMEQLFTVHHEMGHVQYYL

Drosophila                    -----------------------------------------

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	30 – 1306	Angiotensin-converting enzyme
Chain	30 – 1232	Angiotensin-converting enzyme, soluble form
Topological domain	30 – 1256	Extracellular
Domain	40 – 624	Peptidase M2 1
Active site	391 – 391	Proton acceptor 1
Binding site	390 – 390
Binding site	394 – 394
Alternative sequence	1 – 641	MGAASGRRGPGLLLPLPLLLLLPPQPALALDPGLQPGNFSADEAGAQLFAQSYNSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQNFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSNMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWNATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLQAGSSRPWQEVLKDMVGLDALDAQPLLKYFQPVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGID -> MGQGWATAGLPSLLFLLLCYGHPLLVPSQEASQQVTVTHGTSSQATTSSQTTTHQATAHQTSAQSPN. In isoform 4.
Alternative sequence	1 – 574	Missing. In isoform Testis-specific.
Mutagenesis	391 – 391	E -> D. Abolished peptidase activity, leading to increased levels of amyloid-beta; when associated with D-989.

Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.